A prominent figure in the pharmaceutical sector has raised concerns about the ongoing difficulties in delivering essential medications to patients suffering from chronic non-communicable diseases (NCDs). Marlon Ward Rogers, President of the Barbados Pharmaceutical Society, highlighted the dual challenges of supply chain disruptions and escalating drug prices during a recent interview with Barbados TODAY. NCDs, which include conditions such as diabetes and hypertension, are responsible for 80% of deaths in the region, underscoring the urgency of addressing these issues. Ward Rogers emphasized the critical need for public awareness and patient education to ensure adherence to medication regimens and regular health check-ups. Despite these challenges, he assured that there is currently no shortage of drug supplies, though patients may face higher costs for certain medications. He attributed the intermittent shortages to global supply chain issues exacerbated by the COVID-19 pandemic and geopolitical tensions, such as the war in Ukraine. Ward Rogers also noted that while brand-name medications might occasionally be unavailable, generic alternatives often remain accessible. As he begins his new term leading the society, his focus will remain on advancing the pharmacy profession and ensuring patients receive optimal care, including through enhanced continuing education initiatives.